ArticleBlood advances2022

Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab.

Kitsada Wudhikarn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.